Drug Discovery
15th & 16th June 2009, Fairmont Le Montreux Palace, Montreux, Switzerland
Drug Discovery is administered by Osney Media.
Speakers

Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during panel and round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delegates.

 

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Mike Burden at m.burden@oxfordglobal.co.uk

 

2009 Advisory Panel Includes:

 

Gerhard Mueller, Managing Director and CSO, Proteros fragments GmbH

 

Bahija Jallal, Vice President, Translational Sciences, MedImmune

 

Samantha O’Connor, Director, Worldwide Business Development, Pfizer

 

Martin Klumpp, Lab Head Assay Development and Screening, Novartis

 

Emilo Diez, Site Director, Molecular Discovery Research, GlaxoSmithKline

 

Anthony Davies, HCA Research Facility Manager, Trinity College Dublin

 

Tim Hammonds, Head of Biochemistry and HTS, Cancer Research Technology

 

Taoufik Ouatas, Senior Scientist, Exploratory Development Department, Astellas Pharma Europe B.V

 

Zoran Rankovic, Associate Director, Medicinal Chemistry, Organon UK, Schering-Plough

 

2009 speakers:

 

 






Aldermar Degroot, Translational Scientist, Translational Medicine Group Leader, Astellas
Nicolas Frey, Global Head of Modelling and Simulation, F. Hoffman-La Roche
Philip Hajduk, Senior Project Leader, Structural Biology and Lead Discovery, Abbott Laboratories
John Haurum, Chief Scientific Officer, Symphogen A/S
Jonathon Knowles, President of Group Research F. Hoffman-La Roche
Ismail Kola, Senior Vice President, Discovery Research, Early Clinical Research and Experimental Medicine, Schering Plough
Phil L'Huillier, Director, Business Management, Cancer Research Technology Limited
Jonathon Mason, Divisional Director, Early Lead Generation and Computational Chemistry, Lundbeck Research
Lorenz Mayr, Executive Director, BioChemical Assay Development & Screening, Novartis
Andy Merritt, Director Discovery Medicinal Chemistry, GlaxoSmithKline
Shintaro Nishimura, Senior Director, Bioimaging, Astellas Japan
Philip Oliver, Associate Director for Global External R&D Europe, Eli Lilly
Paul Passier, Senior Scientist Exploratory Medicine, Astellas
Graham Richards, Former Head of Chemistry Department, Oxford University
Hans Guenter Schaefer, Director, Clinical Pharmacokinetics/Pharmacodynamics, Boehringer Ingeleheim
Bernd Seihelmer, Head Global R&D Risk Management, Bayer Schering
Thomas Senderovitz, Vice President Global Exploratory Development, UCB Pharma SA
Ted Torphy, CSO and Head, External Research & Early Development, Johnson & Johnson
Lex Van der Ploeg, Vice President Basic Research, Site Head Research Laboratories Boston, Merck
Chris van Koppen, Director, Molecular Pharmacology, Schering-Plough Corporation
Malcolm Weir, CEO, Heptares Therapeutics
Alan Wilson, Vice President Drug Metabolism, Pharmacokinetics and Toxicology, Lexicon Pharmaceuticals
Ming-Qiang Zhang, Vice President Research, Biotica Technology Ltd
Home | Programme | About the Event | Event Format | Speakers | Delegates | Solution Providers | Media Partners | Press Centre | Testimonials | Venue | Organisers | Other Events | Contact | Book Online | 
© Drug Discovery